Our website uses cookies to enable essential features and improve your browsing experience. Additionally, cookies enhance overall website functionality and user experience. By choosing I Accept, you agree to our use of non-essential cookies and other tracking technologies.

You have the ability to manage your settings or withdraw your consent at any time. We are committed to maintaining the privacy and security of your personal information. For detailed information on how we use cookies, including how to manage your privacy and preferences, please visit our cookie policy .
Developmentaid logo
Register
Print
Print
Gates Foundation

Global: To Understand Factors and Evidence Affecting Antimalarial Efficacy and the Production of Evidence to Optimally Use Existing Antimalarials, Visceral Leishmaniasis and Lymphatic Filariasis Treatments, and to Develop New Drugs and Treatments

Last update: 2 days ago Last update: Dec 4, 2025

Details

Locations:UK
Start Date:Nov, 2020
End Date:Feb, 2026
Contract value: USD 4,901,993
Sectors:Health, Research & Innovation
 Health, Research & Innovation
Categories:Grants
Funding Agencies:
Gates Foundation
Date posted:Dec 4, 2025

Associated funding

Associated experts

Description

Purpose: To understand factors and evidence affecting antimalarial efficacy and the production of evidence to optimally use existing antimalarials, visceral leishmaniasis and lymphatic filariasis treatments, and to develop new drugs and treatments
Division: Global Development, Global Health
Region served: GLOBAL
Grant topic: Global Health and Development Public Awareness and Analysis, Malaria
Duration (months): 63
Grantee location: Oxford, Oxfordshire, United Kingdom

Want to unlock full information?
Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.
Learn more about our membership benefits
Print